Holding chamber (Spacer) - A potential harbor of pathogenic bacteria

A. Agrawal, G. Nair, A. Uppe, U. Baby (Navi Mumbai, India)

Source: International Congress 2014 – Asthma and COPD devices and treatments
Session: Asthma and COPD devices and treatments
Session type: Thematic Poster Session
Number: 914
Disease area: Airway diseases, Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Agrawal, G. Nair, A. Uppe, U. Baby (Navi Mumbai, India). Holding chamber (Spacer) - A potential harbor of pathogenic bacteria. Eur Respir J 2014; 44: Suppl. 58, 914

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Development of a human COPD model-on-a-chip to mimic disease exacerbation (a small airway-on-a-chip model)
Source: International Congress 2014 – Novel approaches and evidence for drug development in respiratory diseases
Year: 2014

Bacterial resistance induction with prophylactic antibiotics in COPD
Source: International Congress 2014 – COPD markers
Year: 2014

Distribution and outcomes of the new Spanish phenotype-based guideline for COPD
Source: International Congress 2014 – COPD exacerbations
Year: 2014

Comparison of inspiratory flow rates using an innovative dry powder inhaler (DPI) in patients with mild–severe asthma and severe COPD
Source: International Congress 2014 – Rationale behind respiratory drug development
Year: 2014

Airway glucose in COPD exacerbations
Source: International Congress 2016 – Clinical and microbiological aspects of infections in COPD patients
Year: 2016



Targeted lung denervation in the healthy sheep model - A potential treatment for COPD
Source: International Congress 2014 – Rationale behind respiratory drug development
Year: 2014

Effectiveness of a comprehensive management program of fragile COPD patients
Source: International Congress 2014 – Phenotyping and monitoring asthma and COPD
Year: 2014



Decametoxine efficiency in the treatment of infectious exacerbation of asthma
Source: International Congress 2014 – Novel approaches and evidence for drug development in respiratory diseases
Year: 2014


Exacerbator subtypes in the tiotropium safety and performance in respimat (TIOSPIR™) trial
Source: International Congress 2014 – New clinical evidence for asthma and COPD treatments
Year: 2014


Identification of nasal virus infection in patients with COPD exacerbations
Source: International Congress 2014 – COPD: points to ponder
Year: 2014


Value of adding treatment with lyophilized bacterial lysates in reducing COPD exacerbations in COPD patients risk group C and D
Source: International Congress 2014 – Non inflammatory monitoring of airway diseases
Year: 2014


Clinical cure rates in patients treated with azithromycin (AZ) for lower respiratory infections (LRTI) caused by AZ-susceptible (AZ-S) and AZ-resistant (AZ-R) organisms: Analysis of phase 3 clinical trials
Source: International Congress 2014 – Respiratory symptoms in primary care populations
Year: 2014


Relationship between COPD characteristics and airway bacterial load measured using 16S qPCR
Source: International Congress 2015 – Notable abstracts in exacerbations, mechanisms and biomarkers in COPD
Year: 2015


Association between qPCR bacterial load and airway inflammation in COPD
Source: Annual Congress 2013 –COPD: new markers of diseases
Year: 2013

Implications of under treatment of stable COPD (SAVING study)
Source: International Congress 2015 – New data on established treatments for COPD
Year: 2015


Inspiratory flow resistance of marketed dry powder inhalers (DPI)
Source: International Congress 2014 – Modern approach and old dilemmas in lung diseases
Year: 2014



Gold vs GesEPOC: Are they different?
Source: Annual Congress 2013 –Quality of life and respiratory symptoms in primary care COPD populations
Year: 2013

Is therapy adherence with inhaled tiotropium in COPD related to hospitalization, pneumonia or mortality?
Source: International Congress 2014 – New clinical evidence for asthma and COPD treatments
Year: 2014


Evaluation of the use of CAT in COPD. Results of On-Sint study
Source: International Congress 2014 – Clinical assessment of airway diseases
Year: 2014


Impact of chronic obstructive pulmonary disease (COPD) and patients' absence from work in Greece - the GOLDEN II study
Source: International Congress 2014 – Diagnosis and treatment of COPD in primary care
Year: 2014